[ARWR] YoY Quarter Result on 31-Mar-2017 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
03-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q2]
Profit Trend
QoQ- 50.00%
YoY- 70.97%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 23,529 48,148 650 8,986 44 44 44 184.62%
PBT -19,836 23,897 -14,884 -6,043 -20,816 -28,684 -13,983 5.99%
Tax 0 -0 -150 -81 -449 -413 2,797 -
NP -19,836 23,897 -14,884 -6,043 -20,816 -28,684 -13,943 6.04%
Tax Rate - 0.00% - - - - - -
Total Cost 43,364 24,251 15,534 15,028 20,860 28,728 13,986 20.73%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -84.30 49.63 -2,289.45 -67.24 -47,579.11 -65,563.41 -31,868.62 -62.77%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.20 0.25 -0.18 -0.08 -0.35 -0.51 -0.31 -7.03%
EPS Diluted -0.20 0.24 -0.18 -0.08 -0.35 -0.51 -0.31 -7.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.